McMillan Office’s Linde LIN Stock Holding History

McMillan Office’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Sell	2,951 -10	-0.3%	-$5.07K	0.18%	65
2026 Q1	$1.47M	Hold	2,961	–	–	0.19%	66
2025 Q4	$1.26M	Buy	+2,961	New	+$1.27M	0.15%	70

Other funds holding LIN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

McMillan Office's LIN Position: Q2 2026 in Review

McMillan Office reduced its Linde (LIN) stake by 0.34% in Q2 2026, selling an estimated $5.07K and leaving 2,951 shares worth $1.53M. The position accounts for 0.18% of the portfolio, ranked #65.

McMillan Office first reported a position in LIN in Q4 2025 and has held it in 3 quarters since. 2,334 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

McMillan Office held 2,951 shares of Linde worth $1.53M as of Q2 2026.
McMillan Office sold 10 Linde shares in Q2 2026, an estimated $5.07K.
Linde made up 0.18% of McMillan Office's portfolio in Q2 2026, its #65 holding.
McMillan Office first reported a position in Linde in Q4 2025 and has held it in 3 quarters since.
2,334 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.